Crossmark

Prediction model for the risk of ESKD in patients with primary FSGS

Published Online: 2022-07-01

Authors

Zhu, Yuting

Xu, Wenchao

Wan, Cheng

Chen, Yiyuan

Zhang, Chun https://orcid.org/0000-0003-3565-8024
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81961138007, 81974096, 81770711, 81522010)

National Key R&D Program of China (2018YFC1314000)

Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province (2017QYTD20)
License Information

Text and Data Mining valid from 2022-07-01

Version of Record valid from 2022-07-01
More Information

Article History

Received: 16 November 2021

Accepted: 11 June 2022

First Online: 1 July 2022

Declarations

:

: All authors declared that there are no competing interests.

: The research was approved by the Medical Ethical Committee of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (2015–171) and was performed in accordance with Declaration of Helsinki.

: Written informed consent was obtained from each participant before biopsy.

Document is current